[This corrects the article DOI: 10.3892/ol.2015.3719.].
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859470 | PMC |
| http://dx.doi.org/10.3892/ol.2021.12477 | DOI Listing |
Publication Analysis
Top Keywords
erratum antitumor
4
antitumor activity
4
activity gambogic
4
gambogic acid
4
acid nci-h1993
4
nci-h1993 xenografts
4
xenografts met
4
met signaling
4
signaling pathway
4
pathway downregulation
4
Similar Publications
Corrigendum: CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells.
Front Oncol
December 2024
Department of Medicine and Surgery, University of Parma, Parma, Italy.
[This corrects the article DOI: 10.3389/fonc.2022.
View Article and Find Full Text PDFAuthor Correction: Promoting anti-tumor immunity by targeting TMUB1 to modulate PD-L1 polyubiquitination and glycosylation.
Nat Commun
December 2024
MOE Laboratory of Biosystem Homeostasis and Protection, College of Life Sciences, Zhejiang University, Hangzhou, Zhejiang, 310058, China.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!